NIH-funded research R01 grant

Diet, metabolism, and fatty liver in Hispanic/Latino adults

Official title: Epidemiology of diet, metabolism and non-alcoholic fatty liver disease in Hispanic/Latino adults

Funded at Albert Einstein College of Medicine · NIH-11166690 · Data updated 2026-11-12

Researchers are looking at how diet and metabolic products relate to fatty liver disease in Hispanic/Latino adults.

More Fatty Liver research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAlbert Einstein College of Medicine
NIH-funded
Lab location1 site (Bronx, United States)
Project startSeptember 15, 2023
Project endJuly 31, 2026
Funding year2025
Award (this year)$695,447
NIH project number5R01DK134672-03
Project IDNIH-11166690 on NIH RePORTER

Who could benefit from this research

Could help

Adults age 21 or older who identify as Hispanic/Latino and are willing to provide diet information, blood samples, and undergo liver imaging would be ideal candidates.

Less likely to help

People under 21, non-Hispanic individuals, or those whose liver disease is primarily due to alcohol are not the main focus and may not directly benefit.

What this research studies

This project uses data from 16,415 adults enrolled in the Hispanic Community Health Study/Study of Latinos across four U.S. centers, combining detailed diet information with blood-based metabolite measurements. Researchers will pair those molecular measures with state-of-the-art imaging to detect subclinical liver fat and fibrosis so they can find early signs of NAFLD. They will examine metabolites produced by your body and gut bacteria to see which diet-related signals are linked to fatty liver and its progression. The team plans to translate those findings into low-cost risk screening tests and ideas for diet or other interventions to prevent disease.

Why it matters

Potential benefit: If successful, this work could produce simple screening tests and practical diet-based or other prevention strategies to reduce fatty liver and its complications in Latino communities.

How similar studies have gone: Prior research has linked diet, genetics, and metabolites to NAFLD, but few studies have combined large-scale Hispanic cohort data, advanced imaging, and metabolomics at this scale.

Where this research is happening

  • Albert Einstein College of Medicine
    Bronx, United States
    Active

Researchers

  • Principal investigator: Kaplan, Robert C — Albert Einstein College of Medicine
  • Study coordinator: Kaplan, Robert C

Related research

Other NIH-funded projects on the same topics.

  • Role of fat droplets in liver fat and inflammatory signals in NAFLD

    A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.

    NIH research Johns Hopkins University · Baltimore, United States · NIH-11623263

  • Them1 Inhibitors to Help Treat Fatty Liver Disease

    Aims to develop and test small molecule drugs that block Them1 to help people with non-alcoholic fatty liver disease (NAFLD).

    NIH research Cedars-Sinai Medical Center · Los Angeles, United States · NIH-11519341

  • How the TET1 gene affects non-alcoholic fatty liver disease

    Researchers are looking at whether changes in the TET1 gene and DNA 'tagging' (methylation) play a role in adult non-alcoholic fatty liver disease.

    NIH research State University New York Stony Brook · Stony Brook, United States · NIH-11447065

  • Hepatocellular Genetic Clues for Fatty Liver in Hispanic Adults

    A large NIH grant helps researchers study why fatty liver develops in Hispanic adults and how genetics interact with lifestyle to affect risk.

    NIH research University of Texas Rio Grande Valley · Edinburg, United States · NIH-11421441

  • Toxic fats, vitamin B12 loss, and AHR may drive fatty liver disease

    This grant looks at how certain environmental chemicals may trigger liver damage linked to fatty liver disease and how a vitamin found in the blood could be affected.

    NIH research Michigan State University · East Lansing, United States · NIH-11398883

  • Glutamine and T cells in fatty liver disease

    A study explores how liver glutamine levels affect inflammatory CD4+ T cells in fatty liver disease to find potential new ways to reduce liver inflammation.

    NIH research Cincinnati Childrens Hosp Med Ctr · Cincinnati, United States · NIH-11388863

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.